0001209191-22-051141.txt : 20220923 0001209191-22-051141.hdr.sgml : 20220923 20220923162506 ACCESSION NUMBER: 0001209191-22-051141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220921 FILED AS OF DATE: 20220923 DATE AS OF CHANGE: 20220923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JANNEY DANIEL CENTRAL INDEX KEY: 0001198325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38582 FILM NUMBER: 221262630 MAIL ADDRESS: STREET 1: PO BOX 7414 CITY: JACKSON STATE: WY ZIP: 83002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allakos Inc. CENTRAL INDEX KEY: 0001564824 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454798831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: SUITE 500 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-597-5002 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: SUITE 500 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-21 0 0001564824 Allakos Inc. ALLK 0001198325 JANNEY DANIEL PO BOX 7414 JACKSON WY 83002 1 0 1 0 Common Stock 2022-09-21 4 P 0 475000 5.02 A 2546147 I By Alta Partners NextGen Fund I, L.P. Common Stock 6448053 I By Alta Partners VIII, L.P. Common Stock 56293 I By Alta Bioequities L.P. Reports the purchase of shares in the underwritten public offering of common stock of the Issuer. The shares are directly held by Alta Partners NextGen Fund I, L.P. ("APNG I"). Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein. The shares are directly held by Alta Partners VIII, L.P. ("Alta VIII"). Alta Partners Management VIII, LLC ("Alta Management VIII") is the general partner of Alta VIII. The Reporting Person is a managing director of Alta Management VIII and, as such, may be deemed to share voting and investment control with respect to the shares held by Alta VIII. The Reporting Person disclaims beneficial ownership of all shares held by Alta VIII, except to the extent of his pecuniary interest therein. Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. /s/ Daniel Janney 2022-09-23